Argenx permanently grounds studies of high-flying...
Category : Clinical Trial Update 16 December 2025"While argenx has been able to demonstrate the merit of its FcRn drug Vyvgart in multiple autoi...
"While argenx has been able to demonstrate the merit of its FcRn drug Vyvgart in multiple autoi...
Alzheimer’s disease research took an important step forward as Arrowhead Pharmaceuticals dosed...
Roche has released new three-year follow-up findings from its pivotal phase III STARGLO study, offer...
Early-stage ALS research just received a powerful boost. The ALS Association has announced the 2025...
Hoth Therapeutics has released a detailed update on its clinical and preclinical programs. The compa...